Radio- And chemotherapy variably affect the general immunocompetence of lung cancer patients

Panminerva Medica

Volumn 41, Issue 2, 1999, Pages 129-133

  Vuckovic Dekic L ^a   Susnjar S ^a   Stanojevic Bakic N ^a   Radosavljevic D ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Immune system; Lung neoplasms, drug therapy; Lung neoplasms, radiotherapy; Lung neoplasms, therapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; IMMUNOLOGY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MONOCYTE; PROSPECTIVE STUDY; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 0033143553     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vučković-Dekić Lj, Šušnjar S, Stanojević-Bakić N, Rajner L, Frim O. The protective activity of Thymex L against radiotherapeutically-induced cellular immunodepression in lung cancer patients. Neoplasma 1992;39:171-6.
2. Cascio G, Anania A, Mazzetti R, Scapaticci E, Canavera RM, Marrinuzzi G. Bal T lymphocyte subsets are reduced in primary lung neoplasia. Panminerva Med 1993;35:127-30.
3. Venarucci D, Vallese A, Catalini P, Venarucci V. Consideration on diminished immunologic defences in the elderly neoplastic subject. Panminerva Med 1993;35:154-8.
4. Schulof RS, Chorba TL, Cleary PA, Palaszynski SR, Alabaster O, Goldstein AL. T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1. Cancer 1985;55:974-83.
5. Hobbs JR. Secondary deficiencies of cell-mediated immunity: treatment with thymic factors. In: Pešić M, editor. Thymuspeptide, Thymusenzyme, Thymushormone in Forschung und Therapie. Bad Harzburg: Thymus Fachbuchverlag, 1992:35-45.
6. Milas L, Hanson WR. Eicosanoids and radiation. Eur J Cancer 1995; 3117:1580-5.
7. Vučković-Dekić Lj, Stanojević-Bakić N. Eicosanoids, cancer, and irradiation. Arch Oncol 1996;4:213-8.
8. Winkelstein A. Immune suppression resulting from various cytotoxic agents. Clin Immunol Allerg 1984;4:295-301.
9. Mihich E, Ehrke MJ. Immunomodulation by anticancer drugs. In: De Vita VT Jr., Hellman S, Rosenberg SA, editors. Biologic therapy of cancer. Philadelphia: JB Lippincott Co, 1991:776-86.
10. Ehrke MJ. Effect of anticancer therapy on host response and immunobiology. Curr Opin Oncol 1991;3:1070-7.
11. Penn I. Neoplasia: An example of plasticity of the immune system. Transplant Proc 1996;28:2089-93.
12. Wybran J, Fudenberg HH. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections and other diseases. J Clin Invest 1973;52:1026-32.
13. Rivero I, Abaca HE, Vallis R. A simple method to detect complement receptors using baker's yeast: YC-rosettes. Scand J Immunol 1979;9: 9-14.
14. Vučković-Dekić Lj, Stanojević-Bakić N. Dekić M, Frim O. Continuous versus split-course irradiation for lung cancer. Immunologic implications. Arch Immunol Ther Exp 1995;43:333-6.
15. Young MRI. Eicosanoids and the immunology of cancer. Cancer Metastasis Rev 1994;13:337-48.
16. Stanojević-Bakić N. Vučković-Dekić Lj, Frim O. Šušnjar S, Spužić I. Effect of radio- and chemotherapy on indomethacin modulation of lymphoproliferative response in vitro of lung cancer patients. Lung Cancer 1993;8:309-18.
17. Dunn PL, North RJ. Selective radiation resistance of immunologically induced T cells as the basis of irradiation-induced T-cell-mediated regression of immunogenic tumor. J Leukoc Biol 1991;49: 388-96.
18. Tatara M, Tvorroskova K, Virsik Z. Changes in the intrinsic fluorescence of lymphocytes after irradiation. Studia Biophys 1989;131: 67-73.
19. Seki H, Iwai K, Kanegane H, Konno A, Ohta K, Ohta K et al. Differential protective action of cytokines on radiation-induced apoptosis of peripheral lymphocyte subpopulations. Cell Immunol 1995;163:30-6.
20. Onsrud M, Graham I, Gaudernak G. Early stage carcinoma of the uterine cervix. Effects of intracavitary radium treatment on lymphoid cells in blood and pelvic lymph nodes. Acta Radiol Oncol 1986;25:127-30.
21. Vučković-Dekić Lj. Stanojević-Bakić N, Durbaba M. Šorlević Š. Dynamics of spontaneous recovery from radiotherapy-induced immunodepression in cervical cancer patients: A three-year follow-up. J Exp Clin Cancer Res 1996;15:185-90.
22. Rak J, Strzadala L, Kusnierczyk H, Radzikowski C. Transplantable mouse 16/C mammary adenocarcinoma as a model in experimental cancer therapy. II. Modification of tumor-host interactions by therapeutic procedures. Arch Immunol Ther Exp 1989;37:379-88.
23. Muenchen HJ. Enhanced immunostimulation by novel platinum anti-cancer agents. Anti-Cancer Drugs 1997;8:323-8.
24. Handzel ZT, Burstein Y, Buchner V, Pecht M, Trainin N. Immunomodulation of T cell deficiency in humans by thymic humoral factor: from crude extract to synthetic thymic humoral factor-γ2. J Biol Resp Modif 1990;9:269-78.
25. Ehrke MJ, Mihich E, Berd D, Mastrangelo MJ. Effects of anticancer drugs on the immune system in humans. Semin Oncol 1989;16:230-53.